Introduction: The purpose of this DNP project was to establish baseline human papillomavirus (HPV) vaccination rates, improve baseline knowledge of HPV and HPV vaccines, reduce barriers to HPV vaccination, and increase intention of HPV vaccine uptake among college students.
Methods: A precaution adoption process model-based survey, in-person education session, and posteducation survey were administered to college students in a Midwestern university to measure perceptions of HPV and HPV vaccination as well as to identify barriers to HPV vaccination.
Results: From the preeducation survey to the posteducation survey, correct answers to questions increased, and barriers and misconceptions about HPV and the HPV vaccine decreased, indicating successful education. HPV vaccination intent, defined as indication of "likely" or "very likely" to receive the vaccine on the surveys, rose from 28.0% to 90.7% among participating college students.
Conclusion: This study showed that implementing engaging, in-person HPV prevention education is an effective method for decreasing barriers related to vaccination and increasing vaccination intention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.NPR.0000000000000163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HPV vaccination willingness among 3,081 secondary school parents in China's capital.
Hum Vaccin Immunother
December 2025
Department of Planned Immunization, Chaoyang District Centre for Disease Control and Prevention, Beijing, China.
Assessing knowledge of HPV and HPV vaccine and vaccine willingness among Beijing secondary school parents, and identifying decision-influencing factors. Selected via multi-stage stratified sampling, 3,081 Chaoyang secondary school students' parents participated in a June-August 2024 study. They completed a questionnaire assessing HPV knowledge, vaccine awareness, and vaccination willingness.
View Article and Find Full Text PDFTherapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma.
Curr Opin Oncol
March 2025
Centre Léon Bérard, Lyon, France.
Purpose Of Review: Recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) remains a significant therapeutic challenge due to its biological complexity and clinical heterogeneity. This review addresses the relevance of exploring novel therapeutic approaches, particularly in light of recent advances and the persistent unmet needs in patient outcomes.
Recent Findings: Recent phase II and III clinical trials have highlighted promising strategies, including combinations of immunotherapy with targeted therapies, antibody-drug conjugates (ADCs), HPV vaccines, dual immunotherapy approaches, and therapies targeting the tumor microenvironment.
Adolescent Attitudes Toward the Human Papillomavirus (HPV) Vaccine in Kocaeli, Turkiye.
Cureus
February 2025
Pediatrics, Kocaeli University, Kocaeli, TUR.
Background The adolescent human papillomavirus (HPV) vaccination rate is relatively high in developed countries and it is not widespread in Turkiye. This paper explores what factors influence the decision on the acceptance of the HPV vaccine by adolescents. Methods Data from 206 adolescents was gathered via a survey completed after consent from the parents and themselves between May 2022 and September 2022.
View Article and Find Full Text PDF[Are we hopefully on the way to eradicating HPV-related cancer?].
Lakartidningen
March 2025
docent, överläkare, dermatologi och venereologi, Karolinska universitetssjukhuset, Stockholm; institutionen för medicin, Karolinska institutet.
An interesting article in this issue of Läkartidningen argues for the benefit of a broad HPV vaccination with catch-up vaccination also for men, and sheds more light on HPV-related cancer in men. There has been an increase of HPV-related anal and oropharyngeal cancer in recent years, but no screening methods for these cancers have been implemented. A gender neutral catch-up vaccination would help to decrease the burden of oncogenic HPV in society, and would also be beneficial for females.
View Article and Find Full Text PDF[Catch-up vaccination prevents HPV infection and related precancers when given up to age 26].
Lakartidningen
March 2025
docent, överläkare, Karolins-ka universitetssjukhuset, Stockholm.
HPV-related cancers in men, particularly anal and oropharyngeal cancers, are increasing in Sweden and globally. Men who have sex with men, trans persons and people living with HIV are at especially high risk. HPV vaccination effectively prevents HPV infection and related precancers when given up to age 26.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!